tiprankstipranks
TipRanksTop Financial ExpertsInsidersKaren Prange

Karen Prange Insider Profile

11 Followers
Karen Prange, Director at Atricure, holds 22.81K shares in Atricure (Ticker: ATRC), holds 29.33K shares in Outset Medical (Ticker: OM), holds 64.58K shares in Embecta Corporation (Ticker: EMBC). Most recently, Karen Prange Sold ― shares of Atricure on Aug 07, 2026 for an estimated value of $138.28K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Karen Prange

Karen Prange
Atricure (ATRC)
Director

Ranked #96,191 out of 109,030 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-31.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$10M
58.25%
24.39%
13.04%
3.34%
0.99% Others
A breakdown of Karen Prange's holdings
See the Top Stocks by Insiders

Insider Roles

Henry Schein
(HSIC)
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Boston Scientific
(BSX)
SVP&Pres, Uro & Pelvic Health
Atricure
(ATRC)
Director
Embecta Corporation
(EMBC)
Director
+2 other positions
Roles that Karen Prange holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Atricure
(ATRC)
Rating:Informative Sell
Date:Jun 12, 2023 - Jun 12, 2024
Return:+53.20%
The most profitable trade made by Karen Prange
See the Latest Stocks Traded by Insiders

Karen Prange's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ATRC
Atricure
Aug 07, 2026
Director
Informative Sell
138.28K
$1.24M
NVRO
Nevro Corp
Apr 03, 2025
―
Uninformative Sell
―
$0.00
CMD
Cantel Medical
Jul 31, 2020
―
Uninformative Buy
―
$155.52K
VRAYQ
Viewray
Jul 21, 2023
Director
Informative Sell
8.31K
―
EMBC
Embecta Corporation
Feb 13, 2026
Director
Uninformative Buy
―
$319.03K
OM
Outset Medical
Jun 05, 2026
Director
Uninformative Buy
―
$94.16K
BSX
Boston Scientific
Mar 08, 2016
SVP&Pres, Uro & Pelvic Health
Uninformative Sell
254.68K
$2.33M
HSIC
Henry Schein
Mar 06, 2018
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Uninformative Buy
―
$5.56M
List of latest transactions for each holding click on a transaction to see Karen Prange's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Karen Prange insider profile FAQ

What is the percentage of profitable transactions made by Karen Prange?
The percentage of profitable transactions made by Karen Prange is 33%.
    What is the average return per transaction made by Karen Prange?
    The average return per transaction made by Karen Prange is -31.40%.
      What stocks does Karen Prange hold?
      Karen Prange holds: ATRC, NVRO, CMD, VRAYQ, EMBC, OM, BSX, HSIC stocks.
        What was Karen Prange’s latest transaction?
        Karen Prange latest transaction was an Informative Sell of $138.28K.
          What was Karen Prange's most profitable transaction?
          Karen Prange’s most profitable transaction was an Informative Sell of ATRC stock on June 12, 2023. The return on the trade was 53.20%.
            What is Karen Prange's role in Atricure?
            Karen Prange's role in Atricure is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.